These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1217 related articles for article (PubMed ID: 17325480)
1. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related]
2. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related]
5. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
6. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
7. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687 [TBL] [Abstract][Full Text] [Related]
9. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of cutaneous spindle cell carcinoma. Morgan MB; Purohit C; Anglin TR Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176 [TBL] [Abstract][Full Text] [Related]
12. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Jones EC; Young RH Mod Pathol; 1997 Sep; 10(9):908-16. PubMed ID: 9310954 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341 [TBL] [Abstract][Full Text] [Related]
14. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871 [TBL] [Abstract][Full Text] [Related]
15. Invasive micropapillary urothelial carcinoma of the bladder. Lopez-Beltran A; Montironi R; Blanca A; Cheng L Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120 [TBL] [Abstract][Full Text] [Related]
16. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Lane Z; Epstein JI Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418 [TBL] [Abstract][Full Text] [Related]
17. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases. Leroy X; Gonzalez S; Zini L; Aubert S Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462 [TBL] [Abstract][Full Text] [Related]
18. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Yin H; Leong AS Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]